For as long as it has had a name, Sjögren’s has been treated as a dryness problem.

Dry eyes. Dry mouth. Use the drops. Drink more water. “It’s mild.” “It’s a nuisance condition, not a serious one.” “You’re a busy woman with a lot on your plate, of course you’re tired.” “Your bloods are normal.” “That part is probably fibromyalgia.” “The rheumatology waiting list is over a year.”

The same short list of answers, handed to millions of women whose bodies feel cemented every morning, whose feet burn every night, and whose hands went numb at 2 AM years before anyone said the word Sjögren’s. All of them built on one assumption: that if the eyes are dry and the mouth is dry, the disease lives in the eyes and the mouth. And everything else is something else.

But dry eyes don’t explain the fatigue that nine hours of sleep doesn’t touch. Dry mouth doesn’t explain the morning stiffness, the joint pain that moves from the wrists to the hips, the burning in the feet, or the word that vanishes mid-sentence.

Something has to be producing all of it.

A gland problem was never really an explanation for a whole-body illness. It was the best medicine could do with an incomplete picture.

In 2026, that picture is finally complete. And it points to one place almost nobody was looking:

The neck.

Thousands with Sjögren’s are getting their lives back. The version of themselves they were before the diagnosis, before the drops and the lozenges and the humidifier on the nightstand. Not through another prescription. Not through another protocol. Through a discovery that traces back to what the body did to one line in the neck when the immune system switched on, and never switched off.

It went into survival mode. It clamped down around that line and cut its supply to fund the fight. And the change it left behind never resolved on its own, quietly producing every symptom that defines Sjögren’s ever since.

It was never visible on a standard test, because no standard test was ever designed to look at the neck. Only at the glands on the end of the line.

And once that finding is understood, Sjögren’s stops looking like a gland disease getting worse, with a dozen unrelated side effects.

It starts looking like what it is. A deficiency, in one place, that nobody told you about. And deficiencies can be corrected.

There is a reason every test kept coming back normal. And it is not the reason patients were given.

A Schirmer strip measures how many tears the eye produces in five minutes. A salivary flow test measures how much saliva the mouth produces in fifteen. Bloodwork looks for two antibodies, and comes back negative in nearly one in three people who have the disease. A lip biopsy takes a piece of the gland itself and counts the immune cells inside it.

Every standard test a Sjögren’s patient has ever been given was built to examine one thing at a time. The tears. The saliva. The blood. The gland.

None of them were built to examine the line the gland hangs on.

Most people with Sjögren’s have already been told what’s wrong. That their immune system is attacking the glands that make tears and saliva. That the glands are scarring. That the disease is systemic, that it goes beyond the glands, that it causes fatigue and joint pain and nerve symptoms too.

All of that is right.

What nobody told them is why. Why a gland disease produces exhaustion that nine hours of sleep doesn’t touch. Why it produces a body that wakes up cemented. Why the feet burn. And why the dryness and the fatigue and the stiffness all arrived in the same season, and never left.

The answer is a line that runs through the deep muscles of your neck.

Your tear glands and your saliva glands don’t run themselves. The parotid and submandibular glands, the ones that make your saliva, sit physically in your neck and jaw. Your tear glands sit just above. None of them makes a single drop on its own.

They produce on two things. A nerve signal that gives the order. And a blood supply that brings the water. Both travel through the same few inches of your neck, wrapped inside the deep muscles at the base of the skull.

One of the switchboards on that line has a name you will find in every anatomy textbook and on almost no Sjögren’s chart: the superior cervical ganglion, a nerve centre in the upper neck that helps command your tear and saliva glands.

In a healthy body, the muscles around that line are soft and the line is open. Nothing is felt from it, because nothing is supposed to be. It is invisible by design.

Two things about this line matter more for Sjögren’s than for any other condition.

First: it is the command line for every gland that keeps you wet. Glands don’t make water. They draw it from the blood that reaches them, on the order that reaches them. If either one stops arriving, the gland goes quiet, no matter how healthy it is.

The gland is the tap. The neck is the line that feeds the tap.

Second: in Sjögren’s, the nerves are hit first. Years before the dryness. The newest neurology research has the order of the disease written out in black and white.

Read that again. The tingling hands. The burning feet. The numbness that made you shake your hand awake at 2 AM. For most patients, that arrived years before the dry eyes did.

Medicine had the order of the disease backwards. The dryness was never chapter one. It was chapter three.

And the damage shows up exactly where you’d expect it to.

Which raises the question every patient asks next. What happens to that line when the immune system switches on, and never switches off?

The answer starts with the trigger.

Most people with Sjögren’s can name the season it started. A virus: glandular fever, the flu, and since 2020, overwhelmingly COVID. A pregnancy. The years around menopause. A stretch of caregiving or grief that ran the body into the ground. Something that put the body into survival mode, the same emergency response every human body runs during a serious threat.

In Sjögren’s, that emergency doesn’t end. The immune system stays switched on. Researchers can measure it directly: the majority of Sjögren’s patients carry a pattern in their blood called an interferon signature, the same chemical state the body runs during an active viral infection.

Except there is no virus. The body is fighting, around the clock, for years.

Nobody is giving you interferon. So what has been keeping your alarm switched on, every day, for years?

During survival mode, the body does two things it has done for as long as there have been human bodies.

First, it braces. The deep muscles of the neck and shoulders are the body’s armor, and in fight-or-flight they clamp by reflex. You’ve felt it after one bad week. A Sjögren’s body holds that clamp for a decade.

Second, it reroutes. To fuel the fight, it redirects blood and nutrients toward the organs it cannot afford to lose, the heart, the lungs, the brain, and pulls them away from everything it can run lean on for a few weeks.

This is not new science. It has been an accepted, well-mapped part of human physiology for four decades. Every human body does it. Every human body is supposed to.

For most people, this is invisible and temporary. The virus clears, the clamp lets go, full supply returns, and nothing lasting happens.

In Sjögren’s, the switch never flips back.

The immune system stays on. The neck stays clamped. And the line that commands your glands keeps running on a fraction of what it needs, for years. Month by month, the squeeze gets tighter.

And a squeezed line does three things to the glands at the end of it, at the same time.

The signal gets choked. The instruction to make tears, to make saliva, gets physically muffled on the way to the gland. The gland isn’t broken. It’s not receiving.

The tank runs dry. The nerve centres in the neck regulate the blood flow the glands draw their water from. Squeezed, they throttle it. The tears thin. The saliva thins. Not because the tap broke. Because the line feeding it is pinched. It is also why the pills that force the glands to work, like Salagen, help for a while and then stop. Shouting louder down a phone line someone is standing on doesn’t get the message through.

The junction boxes misfire. The sensory ganglia beside the vertebrae, already under immune attack, are now also under pressure. A nerve under constant pressure doesn’t go quiet. It fires. Burning where there is no heat. Tingling where there is no touch.

So the eyes and the mouth aren’t failing glands. They’re healthy glands on the end of a squeezed line, with their supply cut and their orders choked.

And here is the part that changes everything. The line doesn’t stop at the glands. The same clamped neck that is choking them is sending a constant stream of alarm signals to the entire body, telling it there’s an emergency. So the body can’t leave survival mode, because the neck keeps telling it there’s a threat. And the neck keeps clamping, because the body is locked in survival mode.

A loop. Running day and night, for years. That is why, on its own, it never resolves.

Why the dryness and the fatigue and the stiffness and the burning all started in the same season. And why doctors kept chasing it in the wrong places.

For the roughly one in three people with Sjögren’s who have also been handed a fibromyalgia diagnosis, often before the Sjögren’s was found, this is worth sitting with. A nervous system locked in survival mode, firing alarm signals from a clamped neck, is exactly what fibromyalgia looks like on paper. It was never two diseases. It was one loop, given two names.

For years, Sjögren’s patients have been told it’s just dry eyes. Told it’s mild. Told the fatigue is menopause, the stiffness is fibromyalgia, the burning is anxiety. Told their bloods were normal so there was nothing to treat. Left to explain to husbands, employers and dentists why a “dryness condition” has taken the life they had, while their GP told them the bloods were fine and the rheumatology waiting list stretched past a year.

Now, for the first time, every symptom above is explained by the same finding. One line, squeezed in one place, choking the glands and sounding the alarm everywhere at once.

Not a gland problem with side effects. Not a mystery. Not something in your head. Not something more drops would have fixed.

And that changes what this actually is. A muscle clamped around a nerve line is not destroyed tissue. Nothing in the line is broken. What the research describes is a deficiency: a line at the base of the neck running short of three things. Signal. Blood supply. Cellular energy.

Sjögren’s symptoms aren’t a disease getting worse. They’re a deficiency at the base of your neck. And you were never told.

That distinction is everything. A disease is something you manage for the rest of your life. A deficiency is something you correct.

Which is exactly why nobody built a business around correcting it. They treat it like a disease. They bill for it like one. They refill it like one, every month, for life.

Most people who have had Sjögren’s for any length of time have cycled through the standard shelf.

Systane. Hyabak. Ikervis on a private prescription. Punctal plugs. Pilocarpine and the sweating that comes with it. Biotène. Xylitol lozenges. Hydroxychloroquine. Prednisolone. Methotrexate. LDN. Omega-3 by the handful. Hyaluronic acid drops. The humidifier. And a private dentist’s estimate for £4,000 of crowns.

And every one of them comes with the same pattern. A small shift, twenty, thirty percent. A plateau. Then a flare, or a cold, or a dry winter, and back to where things started. Or worse.

The reason is simple: every one of them is aimed at the gland, or at the immune markers.

Drops wet the surface for twenty minutes. Plugs keep what little the eye makes from draining away. Salagen forces the gland to squeeze out whatever it has left. Hydroxychloroquine turns the immune markers down, and in the largest placebo-controlled trial ever run on it, 17.9% of patients improved on the drug and 17.2% improved on the sugar pill.

Every treatment on the shelf was designed to push on the output, the tears, the saliva, the antibodies. Not one of them has ever touched the neck. The line is still squeezed. The muscle is still clamped around it. The alarm is still firing. Everything producing the symptoms is still running underneath.

I once drew that loop on the back of a conference programme for a dentist who had spent thirty years putting crowns on women with Sjögren’s. He told me later that one sentence ended his career as he knew it.

Everyone treats the glands. Nobody treats the lock.

It is like watering a plant at the end of a garden hose someone is standing on. And wondering why the soil is dry again by morning.

Which raised the obvious question.

If the line is squeezed, and nothing on the standard shelf was ever aimed at the neck, then the real answer is not another drop, another lozenge, or another pill that dissolves in the stomach and scatters through the whole body.

The real answer is to give the line back the three things it stopped receiving. Release the clamp, so the signal gets through. Refeed the line, so the blood comes back. Recharge the cells, so they can hold the quiet.

The problem was that for decades, the only way to do all three was a clinic. Deep heat in one room. Manual release in another. Medical-grade light in a third. At £150 a session, several times a week, for months. Not an answer for a woman managing this disease on her own.

Every piece existed. The squeezed line. The heat and the release that open it. The wavelengths that reach it. The trials behind them.

And no one had built anything with it. Because the Sjögren’s world was building eye drops and immune drugs, and the red light world was treating athletes.

I’ve been a consultant rheumatologist for over twenty years. I have written “sicca syndrome, supportive care” in more notes than I want to count. That is doctor shorthand for: she’s dry, give her drops. And I will be honest with you: I handed out the same short list of answers as everyone else, because it was all I had.

I even handed it to my own sister. Anne. Eleven years of Sjögren’s. I diagnosed her myself, and I watched the rotation fail her one refill at a time.

The night it broke was Boxing Day, at 3 AM. I found her at my kitchen table with a glass of water and a heating pad on her neck. She looked up and said, “Mike, you’re the doctor. Why does my neck burn every time my eyes are at their worst?”

I didn’t have an answer. So I went and found one.

What changed was reading the nerve data side by side with the light data, and realizing they pointed at the same four inches of the human body.

A physiotherapist colleague had been using clinical red light, deep heat and manual release on cervical patients at £150 a session. I sent him three of my Sjögren’s patients. What came back in their symptom diaries made me cancel my afternoon and start calling engineers.

Then a clinic chain offered to license the protocol for their cervical patients, at £150 a session. I said no. A 58-year-old woman managing this on her own was never going to walk into those clinics three times a week. It had to fit on her kitchen table.

Building it turned out to be the hard part.

The clinic units my colleague used weigh nearly twenty kilos and plug into the wall. The LEDs inside them are medical-grade: they emit at exactly 660 and 850 nanometers, at a power high enough to reach three inches into tissue. The red lights sold on Amazon use cheap chips that drift off-wavelength and put out a fraction of that power. Pointed at the neck, they warm the skin and stop there.

Putting clinical output into something small enough to wrap around a neck, and safe enough to rest against it every evening next to 50°C heat and a massage motor, was a problem nobody had solved. Clinical LEDs at that power run hot. Pack them tight against the skin, and they overheat within minutes.

Three manufacturers told me it couldn’t be done at that size. The fourth sent back a prototype that measured at a third of the output written on the box.

Then a colleague put me in touch with a small medical technology team in California. Two of their engineers had worked on the same LED research NASA used to heal tissue in space. The company was called Revive LED. They didn’t tell me it was impossible. They asked for nine months.

It took eleven prototypes. A custom curved board that holds every LED at the exact angle of the neck. A cooling layer thinner than a credit card, so the light can run at full clinical power for the whole fifteen minutes without overheating. Heat calibrated to hold 50°C, not drift to 60. And every single unit tested on a spectrometer before it ships, because a red light that is 20 nanometers off is not the same treatment.

It’s called the Revive RedLight Pro. It does the three things the research points to, at the same time, on the exact stretch of the neck where the gland line runs. Three clinic sessions a week at £150 is £1,800 a month. This is one device, at the kitchen table, for fifteen minutes.

Anne used the first one. The first evening, the grip at the top of her neck let go. Week three, she slept through the night without reaching for the water glass. Week five, the drops went back in the drawer. Her notes still say Sjögren’s. She just stopped living by the bottle.

The Revive RedLight Pro was built around the three shortages the research identified. Each part gives one of them back.

In their own words, it looked like this. The first morning the tongue wasn’t stuck to the roof of the mouth. Toast at 7 AM, no water. Two chapters in bed without reaching for the drops. An hour on the phone with a sister, no sips. A granddaughter’s recital at 4 PM, stayed for the whole thing, drove home. Real tears at a wedding, for the first time in years.

The loop runs in one direction.

Every month in survival mode is more clamp on the line. Every layer of clamp is less signal and less supply to the glands. Less supply is more alarm. More alarm is deeper survival mode. Which produces more clamp.

That is what sits behind what patients describe as their baseline dropping, quietly, year over year, without anything they try interrupting it. The winter that used to mean a rough month now means a rough season. The drops that used to last an hour now last fifteen minutes. The Salagen that used to help doesn’t anymore, because the line it was shouting down has been squeezed past what it can push through.

And it is why “it’s mild, it won’t progress” so rarely holds. In long-term follow-up, the majority of people with Sjögren’s develop systemic involvement over five to fifteen years. The neuropathy, the fatigue, the stiffness, arriving one after another. The body doesn’t stay mild on a line that keeps tightening. It grows into it.

And there is a point the research keeps describing. In long-standing Sjögren’s, biopsies show working gland tissue gradually replaced by fat and scar. A gland that waits for its order long enough stops being able to answer it. Nobody can tell you exactly where your glands are on that road. Only that it runs one way.

The line today is the most responsive it will ever be. Every month it goes unaddressed, that changes.

Tomorrow morning, one of two things happens.

In one, you wake up and your eyes open on their own. The glass on the nightstand is still full. You eat breakfast without a sip between bites.

In the other, you wake up the way you did today. Eyes glued shut. Tongue stuck to the roof of your mouth. You reach for the drops before your feet touch the floor, and the line in your neck is one more night tighter.

The second morning is the default. It is what happens if nothing changes.

It was never just dry eyes. It was never mild. It was your neck. The glands were just the first place you could see it.